georges eva, a russian wordsmith, a french historian of literature, and a professor at the university of geneva, who told me when i was asked about the crimea, he told me, well, i’m sorry, but russia has a historical right to the crimea, do you remember the fat and sevastopol stories, and i i understood that the situation with this colonial lens regarding ukraine is very difficult for us. my first question is, is it possible for you to generalize how the western academy is currently reacting to this full-scale invasion of the russian federation. can you describe the reactions of people who are with you, for example, in working in italy, you know , the question is extremely difficult, because it all depends on the university, the context, the specific country, and the tradition of slavic studies in a specific country. view of the general characteristics of this issue i cannot even give you, because i can say about my university, i was absolutely amazed when suddenly the whole university, literally at all levels at all levels, responded absolutely positively from the side of ukraine firmly withou

but researchers at the university of geneva disagree they looked at the question of why one of 2 diabetes patients world wide has no access to insulin. and it is, it was all ali's lcd than their actual book. ok, flexibly. tickled is austrian, you men. we were told that analog insulin is much harder to produce than human could public and we wanted to know a little more about the cost of manufacture. i. we got together with colleagues to determine manufacturing cautious by looking at each section of the production line section. the fabric just in a p look with the machine. um yeah, typically my job yaki voltage flipping the cost of all the raw materials required for a vial of insulin. the job then added regulatory costs, which are significant regulatory costs are the bands of licensing a product. some clinical trials are required to demonstrate the drugs effective now, in mouth. we also included a profit margin and the investment costs or infrastructure a lot closer to the manufacturing costs per human. insulin is between $2.50 and $3.50, a vile stuff. for most analog insulin product, when

but researchers at the university of geneva disagree they looked at the question of why one of 2 diabetes patients world wide has no access to insulin. and it is, it's all ali's as seen on that. ok, so book a few k flexibly difficulties. austrian, you men, we were told that analog insulin is much harder to produce than human control. and we wanted to know a little more about the cost of manufacture of iaa we got together with then colleagues to determine the manufacturing cost us by looking at each section of the production line such and the public yesterday an appeal could be much el camino totally madell plum yaki vocal subway jail, flipping that we sent the cost of all the raw materials required for a vial of insulin. makisia, then added regulatory costs, which are significant or i'm them. regulatory costs are the expense of licensing a product to submit clinical trials are required to demonstrate the drugs effectiveness here in mouse. we also included a profit margin and the investment costs for infrastructure of love, closer to the manufacturing cost for human insulin is between $2.5